Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
We compare which high yield ETF is tax efficient for retirement, highlighting tax considerations, holdings, and strategies to maximize after-tax income.
27,106 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
A clear, investor-friendly look at HireQuest's Q1 2026 performance and what the numbers signal for HQI's earnings tra...
Meta Platforms trades near the $630s as investors weigh AI-driven capex against margin gains. A growing capital bill ...
Webull trades in the mid-$6s as analysts outline a possible 50% jump within 12 months, driven by stronger revenue, ex...
Stellantis has faced a painful setback, but a bold turnaround plan could spark renewed interest. This guide breaks do...
Kohl's stock moved in dramatic strides after its latest earnings report, tumbling early before a sharp rally. This ar...
Goldman Sachs and KeyBanc boosted AT&T price targets after the telecom giant unveiled a three-segment reporting model...
Singapore Airlines defends its decision to invest in Air India as it reports record revenue but a steep profit drop d...
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
A weekend of good meals and strong friendships can teach big lessons in budgeting and priorities. Explore how the Fiv...